Autolus Therapeutics plc Annual Interest Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Autolus Therapeutics plc quarterly/annual Interest Expense history and growth rate from 2019 to 2023.
  • Autolus Therapeutics plc Interest Expense for the quarter ending September 30, 2024 was $10.7M, a 113% increase year-over-year.
  • Autolus Therapeutics plc Interest Expense for the twelve months ending September 30, 2024 was $70.3M, a 282% increase year-over-year.
  • Autolus Therapeutics plc annual Interest Expense for 2023 was $45.1M, a 406% increase from 2022.
  • Autolus Therapeutics plc annual Interest Expense for 2022 was $8.91M, a 706% increase from 2021.
  • Autolus Therapeutics plc annual Interest Expense for 2021 was $1.11M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $45.1M +$36.2M +406% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $8.91M +$7.8M +706% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $1.11M +$1.11M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $0 Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.